Jouveinal, S.a.

Other

Sipsy

Societe Industrielle De Produits De Synthese

Claude P Roux

Dieran R Torossian

Gilbert G Aubard

Agnes G Grouhel

Jean-Louis Junien

Xavier B Pascaud

Jacques Bure

Veronique J Lelievre

A system for neutralizing polluting gases from petrol and diesel internal combustion engines, or industrial smoke. The neutralizing system includes modules assembled together or integrated, chosen in accordance with the quantity of pollutant gases and their nature. The modules may include: hollow metal or mineral sphere-type pyrolisis heat cell module containing excrescences forming a large exchange area with polluting gases, or electric heaters, particle and HC filter, polluting gas purification module, sound damping and gas temperature reduction module.

System for neutralizing polluting gases by pyrolysis

3,20-dione-11.beta.-hydroxypregn-4-ene-21-thioacetate-17-butyrate and 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thiopropionate-17-butyrate, are anti-inflamatory agents.

Hydrocortisone-17-oxo-21-thioesters, their preparation and their uses as

3,20-dione-11.beta.-hydroxypregn-4-ene-21-thioacetate-17-butyrate and 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thiopropionate-17-butyrate, are anti-inflammatory agents.

Hydrocortisone 17-oxo-21-thioesters and their uses as medicaments

Aminoethyl imidazole of formula: ##STR1## in which R.sub.1 is a lower alkyl, R.sub.2 is a phenyl or phenoxy radical, optionally substituted by a halogen atom or a lower alkoxy radical, R.sub.3,R.sub.4 and R.sub.5 are a hydrogen atom or a lower alkyl radical and x, y and z have the value 0 or 1, but the values of y and z cannot be the same, together with their acid addition salts with acids. Cytoprotective medicament.

Aminoethylimidazole and cytoprotective and gastric antisecretory

Compounds of formula: ##STR1## wherein A and B each represent, independently of each other, a straight-chained or branched alkyl group having from 1 to 6 carbon atoms or a phenyl group optionally mono- or polysubstituted by alkyl radicals having from 1 to 6 carbon atoms, alkoxy groups having from 1 to 6 carbon atoms or halogen, T and U, independently of each other, represent hydrogen atoms or together form a double bond, V is a hydrogen atom or a methyl group at the .alpha.-position, W is a hydrogen atom or a halogen atom at the .alpha.-position, X is a hydroxy group at the .beta.-position and Y is a hydrogen atom or X and Y may together represent an oxygen atom, and Z.sub.1 is a hydrogen atom, a methyl group at the .alpha.- or .beta.-position, while Z.sub.2 is a hydrogen atom, or Z.sub.1 and Z.sub.2 together form a methylene group. These compounds have anti-inflammatory activity.

Steroids esterified in position 17 and thioesterified in position 21, a

Amino-ether oxides of formula: ##STR1## in which R.sub.1 is lower alkyl, R.sub.2 and R.sub.3 which are the same or different are hydrogen or lower alkyl, R.sub.4 is a phenyl or phenoxy nucleus optionally monosubstituted to trisubstituted by substituents which are the same or different, halogen or lower alkoxy, R.sub.5 is a phenyl radical optionally monosubstituted to trisubstituted by substituents which are the same or different, halogen, lower alkyl, lower alkoxy or nitro, a pyridyl radical or a lower alkyl radical, n is equal to zero, 1 or 2 and p is an integer from 0 to 9, m and q are equal to zero or 1. Local and spasmolytic anaesthetics.

Amino-ether oxides and use thereof in therapy

Method for percutaneous treatment of edemas of humans to reduce their swelling, by percutaneous application of a pharmaceutical preparation comprising an active element consisting of acetazolamide in a concentration of between 1 to 50% incorporated in a vehicle which is compatible with percutaneous administration.

Pharmaceutical preparation for percutaneous treatment of local edemas

Pharmaceutical preparation and method for percutaneous treatment of edemas, with the pharmaceutical preparation comprising an active element consisting of acetazolamide in a concentration of between 1 to 50% incorporated in a vehicle which is compatible with percutaneous administration.

Growing community of inventors

Paris, France

Claude P Roux